These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7909729)

  • 41. Functional implications of neurotransmitter co-release: glutamate and GABA share the load.
    Seal RP; Edwards RH
    Curr Opin Pharmacol; 2006 Feb; 6(1):114-9. PubMed ID: 16359920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of stereotaxically injected scrapie on neurotransmitter systems of mouse cerebellum.
    Quinn MR; Kim YS; Lossinsky AS; Carp RI
    Brain Res; 1988 Apr; 445(2):297-302. PubMed ID: 2897224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative organization of neurotransmitters in the deep cerebellar nuclei of the Lurcher mutant.
    Sultan F; König T; Möck M; Thier P
    J Comp Neurol; 2002 Oct; 452(4):311-23. PubMed ID: 12355415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations in neurochemistry during retinal degeneration.
    Fletcher EL
    Microsc Res Tech; 2000 Jul; 50(2):89-102. PubMed ID: 10891873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical features and molecular genetics of autosomal recessive spinocerebellar degenerations].
    Tsuji S
    Rinsho Shinkeigaku; 2004 Nov; 44(11):785-7. PubMed ID: 15651291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison between MRI and 3D-SSP in olivopontocerebellar atrophy and cortical cerebellar atrophy].
    Hamaguchi H; Kanda F; Hosaka K; Fujii M; Chihara K
    Rinsho Shinkeigaku; 2004; 44(4-5):263-7. PubMed ID: 15287507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System.
    Gazulla J; Ruiz-Gazulla C; Tintore M
    Curr Pharm Des; 2015; 21(34):4989-95. PubMed ID: 26365142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurochemical correlates of spasticity.
    Hall PV; Smith JE; Campbell RL; Felten DL; Aprison MH
    Life Sci; 1976 Jun; 18(12):1467-71. PubMed ID: 7723
    [No Abstract]   [Full Text] [Related]  

  • 49. L-Homocysteic acid as an alternative cytotoxin for studying glutamate-induced cellular degeneration of Huntington's disease and normal skin fibroblasts.
    May PC; Gray PN
    Life Sci; 1985 Oct; 37(16):1483-9. PubMed ID: 2864622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Deciphering Cortical Cerebellar Atrophy through Molecular Genetics].
    Takahashi Y
    Brain Nerve; 2020 Sep; 72(9):947-959. PubMed ID: 32934184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synaptic neurochemical alterations associated with neuronal degeneration in an inherited cerebellar ataxia of Gordon Setters.
    Tiemeyer MJ; Singer HS; Troncoso JC; Cork LC; Coyle JT; Price DL
    J Neuropathol Exp Neurol; 1984 Nov; 43(6):580-91. PubMed ID: 6502189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glutamate metabolism of leukocytes and skin fibroblasts in spinocerebellar degeneration with lowered glutamate dehydrogenase activity.
    Tatsumi C; Yorifuji S; Kajiyama K; Ueno S; Takahashi M; Tarui S
    Acta Neurol Scand; 1989 Jun; 79(6):468-75. PubMed ID: 2782027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered GABAergic system in the living brain of a patient with spinocerebellar ataxia type 8.
    Terada T; Kono S; Konishi T; Miyajima H; Ouchi Y
    J Neurol; 2013 Dec; 260(12):3164-6. PubMed ID: 24162040
    [No Abstract]   [Full Text] [Related]  

  • 54. Looking at cerebellar malformations through text-mined interactomes of mice and humans.
    Iossifov I; Rodriguez-Esteban R; Mayzus I; Millen KJ; Rzhetsky A
    PLoS Comput Biol; 2009 Nov; 5(11):e1000559. PubMed ID: 19893633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normal cerebellar glutamate dehydrogenase protein in spinocerebellar degeneration.
    Rosenberg RN; Banner C
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):666-8. PubMed ID: 2732740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacotherapy of the spino-cerebellar syndromes].
    Berciano J; Pascual J
    Neurologia; 1990; 5(6):200-4. PubMed ID: 1979747
    [No Abstract]   [Full Text] [Related]  

  • 57. Neurochemistry of the auditory system.
    Wenthold RJ
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(5 Pt 2):121-31. PubMed ID: 6112959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissociation of duration-based and beat-based auditory timing in cerebellar degeneration.
    Grube M; Cooper FE; Chinnery PF; Griffiths TD
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11597-601. PubMed ID: 20534501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Research on the existence of "formes frustes" in a family with spinocerebellar degeneration].
    van BEUSEKOM G; STAAL JA
    Ned Tijdschr Geneeskd; 1961 Dec; 105():2519. PubMed ID: 13868713
    [No Abstract]   [Full Text] [Related]  

  • 60. [Spino-cerebellar degenerations].
    ROGER H
    Paris Med; 1948 Jul; 38(26):325-30. PubMed ID: 18876103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.